These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37700391)

  • 21. Is there any relationship between quality of life and polysomnographically detected sleep parameters/disorders in stable myasthenia gravis?
    Tascilar NF; Saracli O; Kurcer MA; Ankarali H; Emre U
    Acta Neurol Belg; 2018 Mar; 118(1):29-37. PubMed ID: 28456888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association Between Myasthenia Gravis-Activities of Daily Living (MG-ADL) and EQ-5D-5L Utility Values: The Additional Effect of Efgartigimod on Utilities.
    Dewilde S; Qi CZ; Phillips G; Iannazzo S; Janssen MF
    Adv Ther; 2023 Apr; 40(4):1818-1829. PubMed ID: 36867327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post-stroke depression in Vietnamese patients is associated with decreased sleep quality and increased fatigue: a one-institution cross-sectional analysis.
    Nguyen TTP; Nguyen TX; Nguyen TC; Nguyen HTT; Nguyen TN; Nguyen TTH; Nguyen HTT; Hoang HB; Vu HTT
    Sleep Breath; 2023 Aug; 27(4):1629-1637. PubMed ID: 36434377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determinants of quality of life in Brazilian patients with myasthenia gravis.
    Mourão AM; Gomez RS; Barbosa LS; Freitas Dda S; Comini-Frota ER; Kummer A; Lemos SM; Teixeira AL
    Clinics (Sao Paulo); 2016 Jul; 71(7):370-4. PubMed ID: 27464292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autologous hematopoietic stem cell transplant for the treatment of refractory myasthenia gravis with anti-muscle specific kinase antibodies.
    Beland B; Hahn C; Jamani K; Chhibber S; White C; Atkins H; Storek J
    Muscle Nerve; 2023 Feb; 67(2):154-157. PubMed ID: 36527328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Myasthenia Gravis-specific Activities of Daily Living scale as a useful outcome measure and in routine clinical management in Polish patients.
    Rozmilowska IM; Adamczyk-Sowa MH; Czyzewski D
    Neurol Neurochir Pol; 2018; 52(3):368-373. PubMed ID: 29370887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physician- and self-assessed myasthenia gravis activities of daily living score.
    Lee HL; Min JH; Seok JM; Cho EB; Cho HJ; Kim YD; Kim BJ
    Muscle Nerve; 2018 Mar; 57(3):419-422. PubMed ID: 28796382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diversity in mental fatigue and social profile of patients with myasthenia gravis in two different Northern European countries.
    Sabre L; Westerberg E; Liik M; Punga AR
    Brain Behav; 2017 Apr; 7(4):e00653. PubMed ID: 28413704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement of fatigue in generalised myasthenia gravis with zilucoplan.
    Weiss MD; Freimer M; Leite MI; Maniaol A; Utsugisawa K; Bloemers J; Boroojerdi B; Howard E; Savic N; Howard JF
    J Neurol; 2024 May; 271(5):2758-2767. PubMed ID: 38400914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hope, Coping, and Quality of Life in Adults with Myasthenia Gravis.
    Koopman WJ; LeBlanc N; Fowler S; Nicolle MW; Hulley D
    Can J Neurosci Nurs; 2016; 38(1):56-64. PubMed ID: 27468602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Causes of symptom dissatisfaction in patients with generalized myasthenia gravis.
    Andersen LK; Jakobsson AS; Revsbech KL; Vissing J
    J Neurol; 2022 Jun; 269(6):3086-3093. PubMed ID: 34806129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characteristics and impairment of activities of daily living among patients with myasthenia gravis with differing degrees of muscle weakness: a real-world study of patients in the US and five European countries.
    Pesa J; Choudhry Z; de Courcy J; Barlow S; Gibson G; Chatterton E; Birija SL; Hahn B; Govindarajan R
    BMC Neurol; 2024 Oct; 24(1):385. PubMed ID: 39395956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatigue is a relevant outcome in patients with myasthenia gravis.
    Tran C; Bril V; Katzberg HD; Barnett C
    Muscle Nerve; 2018 Aug; 58(2):197-203. PubMed ID: 29342314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. QMG and MG-ADL correlations: Study of eculizumab treatment of myasthenia gravis.
    Howard JF; Freimer M; O'Brien F; Wang JJ; Collins SR; Kissel JT;
    Muscle Nerve; 2017 Aug; 56(2):328-330. PubMed ID: 28010051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring impairments and allied health professional utilisation in people with myasthenia gravis: A cross-sectional study.
    Cavanagh N; Shrubsole K; Alsop T; Williams K
    J Clin Neurosci; 2023 Aug; 114():9-16. PubMed ID: 37276742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Smoking and Generalized Manifestations of Myasthenia Gravis.
    Miyazaki Y; Niino M; Sakushima K; Takahashi E; Naganuma R; Amino I; Akimoto S; Minami N; Yabe I; Kikuchi S
    Intern Med; 2022 Jun; 61(11):1693-1698. PubMed ID: 34744112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of symptoms severity, heart rate, and central sensitization for predicting sleep quality in patients with fibromyalgia.
    Lima D; Pacheco-Barrios K; Slawka E; Camargo L; Castelo-Branco L; Cardenas-Rojas A; Neto MS; Fregni F
    Pain Med; 2023 Oct; 24(10):1153-1160. PubMed ID: 37314968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of autoimmune comorbidity on fatigue, sleepiness and mood in myasthenia gravis.
    Alekseeva TM; Kreis OA; Gavrilov YV; Valko PO; Weber KP; Valko Y
    J Neurol; 2019 Aug; 266(8):2027-2034. PubMed ID: 31115673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Investigation and analysis of health-related quality of life in myasthenia gravis patients with myasthenia gravis quality of life-15 Chinese version].
    Miao XH; Lian ZY; Liu J; Chen HX; Shi ZY; Zhou HY; Yang R
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Jun; 50(3):514-520. PubMed ID: 29930422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. One-year follow-up of disease burden and medication changes in patients with myasthenia gravis: From the MG Patient Registry.
    Lee I; Leach JM; Aban I; McPherson T; Duda PW; Cutter G
    Muscle Nerve; 2022 Oct; 66(4):411-420. PubMed ID: 35673964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.